Use of the LC16m8 Smallpox Vaccine in Immunocompromised Individuals Is Still Too Risky

Title
Use of the LC16m8 Smallpox Vaccine in Immunocompromised Individuals Is Still Too Risky
Authors
Keywords
-
Journal
Clinical and Vaccine Immunology
Volume 22, Issue 5, Pages 604-604
Publisher
American Society for Microbiology
Online
2015-04-28
DOI
10.1128/cvi.00782-14

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started